Related Experiment Video
Updated: Oct 5, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Anticoagulation with hirudin for continuous veno-venous hemodialysis in liver transplantation
F Saner1, M Hertl, C E Broelsch
1Department of General and Transplantation Surgery, University Hospital Essen, Germany. fuat.saner@uni-essen.de
Abstract:
Postoperative encephalopathy after orthotopic liver transplantation can be difficult to diagnose. We report a case of heparin-induced thrombocytopenia in a liver transplant patient who had seizures. Due to poor liver function the patient developed hepatorenal syndrome requiring continuous veno-venous hemodialysis (CVVHD). Initially we used heparin as the anticoagulant. After the diagnosis of heparin-induced thrombocytopenia (HIT) was made, we switched to r-hirudin. No serious side effects, e.g. bleeding or immune sensitization, were seen.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
